Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Celgene-CELG -- Ignore unavailable to you. Want to Upgrade?

To: Vector1 who wrote (228)	1/4/1999 7:56:00 PM
From: Miljenko Zuanic	Respond to of 804

V1: I have nice profit from Dec., Jan. and Apr. calls (still have few Apr. calls), so am not anxious to sell shares yet. Regardless that shorts position increased in Dec. stock price did hold pretty well. This one shorts may lost. What I mean to say is that if CELG have some positive news from T sales, or partner, or new T clinical results another 25-50% stock price rise is possible. At that point I may sell part of my holding. Also, we didn't have January effect for some time and maybe this is right year??? On the other hand if buyers dry-up slow slide to 10-12 is possible. Long term, if certain SelCIDs progress is realized, perspective should be OK. Miljenko